Viridian Therapeutics Inc. (VRDN)
NASDAQ · Healthcare
Viridian Therapeutics Inc. Shareholder Equity 2013–2025
Viridian Therapeutics Inc. annual shareholder equity history from 2013 to 2025. Shareholder equity represents the net worth of a company, calculated as total assets minus total liabilities.
- Viridian Therapeutics Inc. shareholder equity as of December 31, 2025: 722.2M, a 7.52% increase year-over-year.
- Viridian Therapeutics Inc. shareholder equity for 2025 were 722.2M, a 7.52% increase from 2024.
- Viridian Therapeutics Inc. shareholder equity for 2024 were 671.6M, a 51.95% increase from 2023.
- Viridian Therapeutics Inc. shareholder equity for 2023 were 442.0M, a 11.89% increase from 2022.
- Viridian Therapeutics Inc. shareholder equity for 2022 were 395.1M.
Shareholder Equity
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Viridian Therapeutics Inc. Annual Shareholder Equity (Millions of US $) | |
|---|---|
| 2025 | $722 |
| 2024 | $672 |
| 2023 | $442 |
| 2022 | $395 |
| 2021 | $188 |
| 2020 | $120 |
| 2019 | $16 |
| 2018 | $51 |
| 2017 | $39 |
| 2016 | $-62 |
| 2015 | $-45 |
| 2014 | $6 |
| 2013 | $-24 |
Viridian Therapeutics Inc. Shareholder Equity — FAQ
Viridian Therapeutics Inc. (VRDN) shareholder equity over the last 13 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see VRDN's shareholder equity history?
The chart and table above show Viridian Therapeutics Inc.'s shareholder equity by year and by quarter, including the growth rate.